Status:
COMPLETED
The VetSeq Study: a Pilot Study of Genome Sequencing in Veteran Care
Lead Sponsor:
VA Boston Healthcare System
Conditions:
Rare Diseases
Genetic Disease
Eligibility:
All Genders
Phase:
NA
Brief Summary
The VetSeq Study is a pilot intervention study exploring the feasibility of integrating genome sequencing into clinical care at the VA Boston Healthcare System.
Detailed Description
The VetSeq Study is a pilot intervention study exploring the feasibility of integrating genome sequencing into clinical care at the VA Boston Healthcare System. Healthcare providers may refer any pati...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patient referred by provider to study for genome sequencing
- Life expectancy of at least 12 months in the judgment of the referring provider
- Exclusion criteria:
- Life expectancy of \<12 months
- Inability to give informed consent
Exclusion
Key Trial Info
Start Date :
December 29 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT03380819
Start Date
December 29 2017
End Date
December 31 2022
Last Update
April 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Boston Healthcare System
Boston, Massachusetts, United States, 02130